Association of Microglial Activation With Spontaneous ARIA-E and CSF Levels of Anti-Aβ Autoantibodies
Authors:
- Fabrizio PiazzaFPFabrizio Piazza
- Silvia Paola CaminitiSCSilvia Paola Caminiti
- Marialuisa ZeddeMZMarialuisa Zedde
- Luca PresottoLPLuca Presotto
- Jacopo C. DiFrancescoJDJacopo C. DiFrancesco
- Rosario PascarellaRPRosario Pascarella
- Alessia GiossiAGAlessia Giossi
- Maria SessaMSMaria Sessa
- Loris PoliLPLoris Poli
- Gianpaolo BassoGBGianpaolo Basso
- Daniela PeraniDPDaniela Perani
Open Access
- 20 September 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 99 (12) , e1265-e1277
Abstract
Background and Objectives Amyloid-related imaging abnormalities suggestive of vasogenic edema or sulcal effusion (ARIA-E) are the most common adverse events complicating Alzheimer disease (AD) immunotherapy with anti–β-amyloid (Aβ) monoclonal antibodies. ARIA-E can also occur spontaneously in cerebral amyloid angiopathy–related inflammation (CAA-ri), a rare autoimmune encephalopathy associated with increased CSF levels of anti-Aβ autoantibodies. Although the pathophysiologic mechanisms of ARIA-E remain to be fully elucidated, experimental evidence from ex vivo studies suggests that gantenerumab and aducanumab enable microglial activation. However, the in vivo evidence for a direct association between neuroinflammation and ARIA-E in patients with high CSF anti-Aβ (auto)antibody levels has never been demonstrated. Methods The spatial distribution and temporal variations of microglial activation associated with levels of anti-Aβ autoantibodies at (sub)acute presentation of ARIA-E and after corticosteroid therapy were evaluated in a longitudinal case series of patients with CAA-ri, the spontaneous variant of the iatrogenic ARIA-E reported in Aβ-lowering immunotherapy with monoclonal antibodies. Multimodal and multiparametric MRI was used for CAA and ARIA-E severity quantification, according to validated scoring system; CSF testing for anti-Aβ autoantibodies and AD biomarkers; 11C-PK11195 PET for activated microglia. Results At (sub)acute presentation, we found focal peaks of microglial activation having a greater spatial colocalization with ARIA-E compared with chronic age-related white matter change imaging abnormalities. The severity of ARIA-E and the magnitude of the associated microglial activation were greater in patients having AD and severe CAA concomitant disease compared with patients having CAA only. CSF anti-Aβ autoantibodies at presentation were high in all patients and markedly decreased at posttreatment follow-up, in parallel with clinical resolution of acute symptoms, reduced ARIA-E severity, and reduced microglial activation. Discussion Our findings extend the current notion of ARIA-E by providing the first in vivo 11C-PK11195 PET evidence for an association between microglial activation and the magnitude and severity of ARIA-E in patients with increased CSF concentration of anti-Aβ autoantibodies and comorbid AD and CAA disease. Our results highlight CSF testing for anti-Aβ autoantibodies as a promising diagnostic, prognostic, and therapy response biomarker to help guide future treatment and management decisions in real clinical practice and clinical trials.Keywords
This publication has 46 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Optimization of Supervised Cluster Analysis for Extracting Reference Tissue Input Curves in (R)-[11C]PK11195 Brain PET StudiesJournal of Cerebral Blood Flow & Metabolism, 2012
- Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivationMolecular and Cellular Neuroscience, 2012
- Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemiaNeuropharmacology, 2011
- Life imitates artNeurology, 2011
- Cholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patientsNeuroscience Letters, 2010
- Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiencyAtherosclerosis, 2010
- Prevalence of superficial siderosis in patients with cerebral amyloid angiopathyNeurology, 2010
- Cerebral microbleeds: a guide to detection and interpretationThe Lancet Neurology, 2009
- Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular functionTrends in Pharmacological Sciences, 2006